BIOXCEL THERAPEUTICS INC (BTAI) Stock Analyst Earnings Estimates
NASDAQ:BTAI - Nasdaq - US09075P1057 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 380K | 1.38M 263.16% | 2.834M 105.36% | 4.164M 46.93% | 15.486M 271.90% | 58.854M 280.05% | 108.68M 84.66% | 169.47M 55.93% | 84.66M -50.04% | 139.54M 64.82% | 199.41M 42.91% | ||
| EBITDA YoY % growth | -106.64M -29.87% | -159.32M -49.40% | -167.301M -5.01% | -77.589M 53.62% | -78.912M -1.71% | -74.984M 4.98% | -32.079M 57.22% | 1.785M 105.56% | 49.419M 2,668.57% | 11.526M -76.68% | 59.16M 413.27% | 111.28M 88.10% | |
| EBIT YoY % growth | -106.94M -29.94% | -159.65M -49.29% | -167.619M -4.99% | -75.312M 55.07% | -70M 7.05% | -68.23M 2.53% | -34.629M 49.25% | 1.224M 103.53% | 48.807M 3,887.50% | 11.016M -77.43% | 58.446M 430.56% | 110.36M 88.82% | |
| Operating Margin | N/A | -42,013.16% | -12,146.30% | -2,657.46% | -1,681.07% | -440.59% | -58.84% | 1.13% | 28.80% | 13.01% | 41.88% | 55.34% | |
| EPS YoY % growth | -4.08 -7.65% | -5.91 -44.90% | -6.15 -4.03% | -27.90 -353.72% | -19.85 28.85% | -14.65 26.23% | -0.87 94.08% | -0.05 94.12% | 0.38 840.00% | 2.69 613.51% | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -6.73 -785.57% | -4.24 -387.72% | -3.64 -8.47% | -3.43 33.06% | -0.23 96.62% |
| Revenue Q2Q % growth | 720.803K 91.70% | 578.003K -0.69% | 782.003K -29.17% | 1.258M 487.85% | 1.564M 116.98% |
| EBITDA Q2Q % growth | -19.311M 1.26% | -18.768M 22.08% | -17.034M -4.60% | -16.881M -24.97% | -16.626M 13.90% |
| EBIT Q2Q % growth | -16.835M 15.29% | -18.819M 22.12% | -17.085M -3.92% | -16.881M -22.86% | -16.728M 0.64% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -5.12 -197.67% | -8.84 | 3.72 | 42.08% |
| Q2 2024 Q2Q % growth | -3.36 -83.61% | -11.59 | 8.23 | 71.00% |
| Q1 2024 Q2Q % growth | -0.87 52.72% | -0.71 | -0.16 | -22.14% |
| Q4 2023 Q2Q % growth | -0.76 61.03% | -0.93 | 0.17 | 18.12% |
| Q3 2023 Q2Q % growth | -1.72 -15.28% | -1.33 | -0.39 | -29.32% |
| Q2 2023 Q2Q % growth | -1.83 -35.56% | -1.79 | -0.04 | -2.47% |
| Q1 2023 Q2Q % growth | -1.84 -64.29% | -1.65 | -0.19 | -11.48% |
| Q4 2022 Q2Q % growth | -1.95 -109.68% | -1.48 | -0.47 | -32.18% |
| Q3 2022 Q2Q % growth | -1.49 -55.42% | -1.38 | -0.11 | -8.35% |
| Q2 2022 Q2Q % growth | -1.35 -21.62% | -1.24 | -0.11 | -8.57% |
| Q1 2022 Q2Q % growth | -1.12 -3.70% | -1.17 | 0.05 | 4.24% |
| Q4 2021 Q2Q % growth | -0.93 -6.90% | -1.13 | 0.20 | 17.41% |
| Q3 2021 Q2Q % growth | -0.96 10.28% | -1.07 | 0.11 | 10.45% |
| Q2 2021 Q2Q % growth | -1.11 -4.72% | -1.11 | 0.00 | -0.30% |
| Q1 2021 Q2Q % growth | -1.08 -36.71% | -0.96 | -0.12 | -12.79% |
| Q4 2020 Q2Q % growth | -0.87 -93.33% | -0.98 | 0.11 | 10.87% |
| Q3 2020 Q2Q % growth | -1.07 -87.72% | -0.81 | -0.26 | -31.31% |
| Q2 2020 Q2Q % growth | -1.06 -96.30% | -0.76 | -0.30 | -38.77% |
| Q1 2020 Q2Q % growth | -0.79 -71.74% | -0.61 | -0.18 | -30.17% |
| Q4 2019 Q2Q % growth | -0.45 | -0.65 | 0.20 | 30.34% |
| Q3 2019 Q2Q % growth | -0.57 | -0.66 | 0.09 | 13.58% |
| Q2 2019 Q2Q % growth | -0.54 | -0.62 | 0.08 | 12.35% |
| Q1 2019 Q2Q % growth | -0.46 | -0.56 | 0.10 | 17.50% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 214K -37.24% | 1.332M | -1.118M | -83.93% |
| Q2 2024 Q2Q % growth | 1.104M 141.58% | 774.384K | 329.616K | 42.56% |
| Q1 2024 Q2Q % growth | 582K 182.52% | 473.28K | 108.72K | 22.97% |
| Q4 2023 Q2Q % growth | 376K 56.67% | 725.353K | -349.353K | -48.16% |
| Q3 2023 Q2Q % growth | 341K 143.57% | 673.2K | -332.2K | -49.35% |
| Q2 2023 Q2Q % growth | 457K | 462.968K | -5.968K | -1.29% |
| Q1 2023 Q2Q % growth | 206K | 509.072K | -303.072K | -59.53% |
| Q4 2022 Q2Q % growth | 240K | 1.273M | -1.033M | -81.15% |
| Q3 2022 Q2Q % growth | 140K | 1.116M | -976K | -87.46% |
| Q1 2022 Q2Q % growth | 127.5K | -127.5K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1206.6% | -985.25% | -1403.11% | -1250.95% |
| Revenue | -47.08% | -30.36% | -11.19% | -40.82% |